These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Wanebo JH, Stearns M, Schwartz MK. Ann Surg; 1978 Oct; 188(4):481-93. PubMed ID: 697433 [Abstract] [Full Text] [Related]
75. [Serum carcinoembryonic antigen doubling time in patients with recurrent gastrointestinal carcinoma and its relationship to tumor biology and life expectancy]. Takesue F, Inutsuka S, Nagahama S, Kusumoto H, Korenaga D, Maekawa S, Ikeda T. Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():464-8. PubMed ID: 9589054 [Abstract] [Full Text] [Related]
77. [Carcino-embryonic antigen as screening protein in the follow-up of patients with surgically-treated gastrointestinal cancer (author's transl)]. Möschl P, Staritz C, Keiler A, Kreuzer W, Fasching W. Wien Klin Wochenschr; 1980 Feb 15; 92(4):128-30. PubMed ID: 7395229 [Abstract] [Full Text] [Related]
79. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract]. Tappero G, Piantino P, Cerchier A, Pecchio F. Minerva Med; 1985 Apr 14; 76(16):765-70. PubMed ID: 2582313 [Abstract] [Full Text] [Related]
80. Preoperative CEA level: a prognostic test in patients with colorectal carcinoma. Kohler JP, Simonowitz D, Paloyan D. Am Surg; 1980 Aug 14; 46(8):449-52. PubMed ID: 7406353 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]